Document ID: chunk:federal_register_of_legislation:F2025L00212:clause:1_281
Version: federal_register_of_legislation:F2025L00212
Segment Type: clause
Provision Reference: sch 1 cl 281
Character Range: 160459–161291

281                                       5-ETHYL-2,3-DIMETHYLPYRAZINE                                                      E         5-Ethyl-2,3,dimethylpyrazine must not be included in medicines for oral administration.

                                                                                                                                      5-Ethyl-2,3,dimethylpyrazine must only be included in topical medicines when in combination with other permitted ingredients as a fragrance proprietary excipient formulation.

                                                                                                                                      The total concentration of the fragrance proprietary excipient formulation containing 5-ethyl-2,3,dimethylpyrazine must not be more than 1% of the total medicine.